Clinical Trial Update: Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study) [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate a urine tumor DNA panel for screening urothelial cancer in individuals with Lynch syndrome (LS-URO Study) at Tampere …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lynch Syndrome
• Urothelial Carcinoma

Snippet

Sponsor: Tampere University Hospital | Conditions: Urothelial Carcinoma, Lynch Syndrome | NA | Status: RECRUITING